Last reviewed · How we verify
Placebo to match OBE2109 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo to match OBE2109 (Placebo to match OBE2109) — ObsEva SA. This is a placebo formulation designed to match the appearance, taste, and administration characteristics of OBE2109 for blinded clinical trial purposes.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo to match OBE2109 TARGET | Placebo to match OBE2109 | ObsEva SA | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo to match OBE2109 CI watch — RSS
- Placebo to match OBE2109 CI watch — Atom
- Placebo to match OBE2109 CI watch — JSON
- Placebo to match OBE2109 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo to match OBE2109 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-to-match-obe2109. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab